Suvorexant is an aromatic amide that acts as a dual antagonist of orexin receptors, promoting sleep by reducing wakefulness and arousal. It is used in pharmaceutical manufacturing as an active pharmaceutical ingredient for the management of insomnia.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1030377-33-3
Suvorexant metabolite M9
pharmaceutical raw material
Daridorexant
pharmaceutical raw material
(R)-(-)-1-Aminoindane hydrochloride
pharmaceutical raw material
(2R)-daptomycin
pharmaceutical raw material
Tribenoside
pharmaceutical raw material
Levamlodipine
pharmaceutical raw material
5-chloro-2-[(5S)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole
pharmaceutical raw material
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
JYTNQNCOQXFQPK-MRXNPFEDSA-N
C[C@@H]1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl